Century Therapeutics strengthens position in autoimmune disease through $60 Million Private Placement and Acquisition of Clade Therapeutics
Acquiring Company
Century Therapeutics
Acquired Company
Clade Therapeutics
PhiladelphiaBostonManufacturingBiotechnologyHealthcareHealth CareTherapeuticsBiotechnologyHealthcareDescription
Century Therapeutics, an innovative biotechnology company, announced the acquisition of Clade Therapeutics, Inc. to further expand its research and development initiatives in autoimmune diseases. This strategic move, combined with a private placement of $60 million, signifies a transformative milestone for Century as it accelerates and broadens its research and development efforts to address significant unmet needs for patients across serious diseases.
Quick answer
Century Therapeutics is acquiring Clade Therapeutics for $60 million, announced April 11, 2024. Century Therapeutics is based in Philadelphia, Pennsylvania, United States.
- How much did Century Therapeutics pay for Clade Therapeutics?
- The reported deal value is $60 million.
- What does Century Therapeutics do?
- Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell..
- Where are Century Therapeutics and Clade Therapeutics based?
- Century Therapeutics is based in Philadelphia, Pennsylvania, United States. Clade Therapeutics is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Century Therapeutics?
- Fundz holds 1 contact at Century Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (March 25, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
Who to call at Century Therapeutics, and when
When Century Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Century Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Century Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Century Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Century Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Clade Therapeutics?
Clade Therapeutics was acquired by Century Therapeutics, based in Philadelphia. The deal was reported on April 11, 2024. Century Therapeutics is privately held and operates in Manufacturing.
When did Century Therapeutics acquire Clade Therapeutics?
Century Therapeutics's acquisition of Clade Therapeutics was reported on April 11, 2024. Century Therapeutics, an innovative biotechnology company, announced the acquisition of Clade Therapeutics, Inc. to further expand its research and development initiatives in autoimmune diseases. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Clade Therapeutics do?
Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.